Wheel Health
Wheel built telehealth infrastructure for the COVID era. When the pandemic ended and telehealth demand normalized, the company's growth thesis evaporated along with its customers' volumes.
2018 → 2024
$216M
HealthTech/Telehealth Infrastructure
USA
IdeaProof AI Failure Score
What Happened: The Timeline
2018
Michelle Davey founds Wheel as white-label telehealth infrastructure
2020
COVID-19 creates massive telehealth demand; Wheel grows rapidly
Jan 2022
Raises $150M Series C led by Tiger Global at $1.5B+ valuation
2023
Telehealth volumes decline post-COVID; key customers shut down or bring in-house
2023
Multiple layoff rounds, strategic pivot to care programs
2024
Significantly downsized, valuation marked down dramatically
Root Causes
Wheel Health was a telehealth infrastructure company that provided white-label virtual care services to other healthcare organizations. Rather than building a consumer-facing telehealth brand, Wheel powered telehealth for companies like Amazon, Ro, and other digital health startups — providing the clinician network, technology platform, and compliance infrastructure needed to offer virtual care. Founded by Michelle Davey, the company raised $216 million, including a $150 million Series C led by Tiger Global in 2022 at a reported $1.5B+ valuation. The investment thesis was compelling: as telehealth boomed during COVID-19, every healthcare company would need virtual care infrastructure, and Wheel would be the 'Twilio of telehealth.' But telehealth utilization peaked during COVID and then declined significantly. Virtual visit volumes dropped as patients returned to in-person care, and many digital health companies that were Wheel's customers either shut down (like Nurx) or brought telehealth capabilities in-house. The massive tailwind that had driven Wheel's growth reversed into a headwind. Throughout 2023-2024, Wheel underwent significant layoffs and restructuring. The company pivoted to focus on care programs and clinical trial support, but these pivots couldn't replace the lost virtual visit volume. Tiger Global, which had led the Series C at peak valuations, marked down many of its 2021-2022 investments including Wheel. The company represents the broader correction in telehealth infrastructure valuations — where COVID-era growth was mistaken for permanent structural change.
Key Lessons Learned
2. B2B infrastructure is only as stable as your customers
Wheel's customers were digital health startups — many of which shut down or downsized in 2023-2024. When your customers fail, your platform revenue fails too.
3. Peak-market fundraising creates impossible expectations
Raising $150M at a $1.5B valuation during peak COVID telehealth demand meant Wheel needed to maintain pandemic-level growth. When volumes normalized, the valuation was unsupportable.
Competitors That Won
Teladoc
Largest telehealth platform, survived (though stock also fell significantly)
Why they won: Direct consumer brand, employer partnerships, diversified services (BetterHelp)
Amazon Clinic
Amazon's direct telehealth service for Prime members
Why they won: Amazon distribution, 200M+ Prime members, integrated pharmacy
Frequently Asked Questions
Sources & References
Could This Failure Have Been Prevented?
IdeaProof's AI validates market demand, competitive positioning, and business model viability in minutes — catching the exact issues that sank Wheel Health.